Health Condition 1: J80- Acute respiratory distress syndrome Health Condition 2: B972- Coronavirus as the cause of diseases classified elsewhere
Conditions
Interventions
Intervention1: Pharmacotherapy evaluation: Our study is mainly focus on patient safety
Intervention is in the pharmaceutical care where dose, duration of therapy, frequency, medical adherence and the
Sponsors
Adichunchanagiri University
Eligibility
Inclusion criteria
Inclusion criteria: Diagnosed with Covid-19 by any diagnostic tool (i.e., RT-PCR, CT scan or X-Ray and any other as per the clinical decision taken by the treating physician).
Exclusion criteria
Exclusion criteria: Those who does not meet inclusion criteria.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| This study can help in rationalization, individualization of drug therapy. The study minimizes the chance of treatment failure and drug related complications. The study can suggest the alternative drugs during drug shortage. This study can prevent the possible drug-drug interaction. Timepoint: 3 years | — |
Secondary
| Measure | Time frame |
|---|---|
| The study can suggest the alternative drugs during drug shortage. This study can prevent the possible drug-drug interaction.Timepoint: immediately | — |
Countries
India
Contacts
Public ContactDr RAVI K S
Sri Adichunchanagiri College of Pharmacy Adichunchanagiri University
Outcome results
None listed